Q5169 Pegfilgrastim-unne - CanMED: HCPCS

Return Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Pegfilgrastim-unne

Brand Name:

Armlupeg

Strength:

0.5mg

HCPCS:

Q5169

SEER*Rx Category:

Ancillary Therapy

Major Drug Class:

Immunostimulant

Minor Drug Class:

Granulocyte Colony-Stimulating Factor

Oral (Y/N):

No

FDA Approval Year:

2026

FDA Discontinuation Year:

CMS Effective Date:

June 17, 2026

CMS Discontinuation Date:

Status:

In Use